Company intelligence / Profile preview

axicorp Pharma

Friedrichsdorf, Hesse, Germany
Ownership
Private
Employees
~250
Development stage
Other
01

Overview

AxiCorp Pharma is a leading German pharmaceutical company specializing in the parallel import of EU-branded pharmaceuticals and the distribution of high-quality generics and biosimilars. Founded in 2002 and headquartered in Friedrichsdorf, the company focuses on providing cost-effective medication across various therapeutic areas, including oncology, HIV, and neurology. AxiCorp operates as a key subsidiary of Dermapharm Holding SE, leveraging a robust supply chain to bridge price differences within the European Union. Their business model emphasizes affordability and accessibility of essential medicines for the German healthcare market. The company also maintains a specialized division, axicorp biotechs, which focuses on the distribution of complex biopharmaceutical products.

Therapeutic areas
CardiovascularNeurologyDermatologyInfectious DiseasesRheumatologyOncology
Modalities
Small moleculeMonoclonal antibodyBiologic
Industry
Non-Academic Healthcare

Beyond the preview

Go deeper on axicorp Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on axicorp Pharma.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call